Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did 😎Read how

Strides Pharma Science Ltd (SRID)

NSE
Currency in INR
Disclaimer
839.35
+6.05(+0.73%)
Closed

SRID Price Commentary

target long term
200
sale on Every Rise, Exit this counter fair value 420 to 440
immediate Target 700+
Tomorrow definitely 650
yes
End of the day Again 580?
target of this share??
what is the target of this share
sooner or later pharma companies will be market leader
target 780 month of April
stop plus 361
star buy enter current level 370 targets 395 413 447 457 483
what will be next level
435 tgt very soon
will achieve 435 tgt very soon.will take 2-3 days
Sir what is the target of this scrip in this series. I hold 200shares at 1282
For tomorrow sure 420
Keep it and watch after two months
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.